###begin article-title 0
Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 471 475 <span type="species:ncbi:10116">rats</span>
Estrogen is known to play role in temporomandibular joint (TMJ) disorders and estrogen effects can be mediated by estrogen receptor (ER) alpha present in the TMJ. Cells expressing the estrogen receptor ERalpha are present in the temporomandibular joint (TMJ) but changes in expression due to estrogen and inflammation have not been characterized. In this study, ERalpha protein content and the number of cells expressing ERalpha was measured in 17 beta-estradiol-treated rats after inflammation was induced in the TMJ.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 30 34 <span type="species:ncbi:10116">rats</span>
###xml 277 280 <span type="species:ncbi:31658">CFA</span>
###xml 386 389 <span type="species:ncbi:31658">CFA</span>
###xml 397 400 <span type="species:ncbi:31658">CFA</span>
###xml 423 427 <span type="species:ncbi:10116">rats</span>
Sixteen ovariectomized female rats were divided into two groups such that one group received 17 beta estradiol (E2) and the other was given vehicle (VEH). Groups were then subdivided further, one received injections of saline and the other received Complete Freund's adjuvant (CFA) within the superior joint space of the TMJ. Thus the four groups include no E2/saline, E2/saline, no E2/CFA and E2/CFA. After treatment, the rats were sacrificed, and the TMJ anterior, disc, retrodiscal and synovial tissues were analyzed by western blot and immunocytochemistry. Positive stained cells were counted using a Nikon epifluorescent microscope.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
The western blot showed that ERalpha protein significantly decreased with inflammation. The number of ERalpha-positive cells in the TMJ was not affected by inflammation or 17 beta-estradiol with exception of the retrodiscal tissue. In the retrodiscal tissue 17 beta-estradiol significantly decreased the number of ERalpha-positive cells but only in a non-inflamed joint.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
In conclusion, inflammation and 17 beta-estradiol can modulate ERalpha expression in the TMJ but the effects are tissue specific.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 73 78 <span type="species:ncbi:9606">women</span>
###xml 306 311 <span type="species:ncbi:9606">women</span>
###xml 868 873 <span type="species:ncbi:9606">women</span>
Epidemiological studies have shown that during their reproductive years, women experience a higher frequency of temporomandibular joint disorders than males with a ratio of = 1.5- 2 [1]. It has been postulated that estrogen could be the primary molecule leading to the higher frequency of TMJ disorders in women. Endogenous estrogen affects the remodeling processes within the TMJ [2,3] possibly by changing the extracellular matrix in the joint [4] or by changing bone volume [2]. Such changes can result in internal derangement of the TMJ. Estrogen modulation of matrix metalloproteinase (MMP) expression has also been observed in the cartilage of the TMJ [5,6]; high levels of MMP have been reported to play a role in TMJ osteoarthritis [7,8]. Moreover, the level of estrogen in the synovial fluid has been correlated to the severity of arthritis in postmenopausal women [9], and in animal models estrogen has been shown to modulate inflammation in the TMJ [10,11].
###end p 10
###begin p 11
###xml 187 189 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 240 242 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 410 412 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 573 575 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
17 beta-estradiol is the most potent and dominant form of estrogen in the human female, having biological effects through binding the estrogen receptor alpha (ERalpha) and beta (ERbeta) [12]. ERalpha and ERbeta acts via binding to the DNA [13] or by having biological effects through interacting with various kinases, such as mitogen-activated protein kinase, phosphatidylinositol-3 kinase or tyrosine kinase [12]. Also both receptors can interact with membrane-associated molecules such as ion channels and G protein-coupled receptors to alter the physiology of the cell [12].
###end p 11
###begin p 12
###xml 82 84 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 85 87 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 103 105 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 119 121 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 293 295 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
The wide distribution of the estrogen receptors ERalpha and ERbeta in the thymus [14,15], bone marrow [16] and spleen [17] suggests that it plays a modulatory role in the immune system, such as modulating differentiation, activation, proliferation and antibody production from lymphoid cells [18]. Immune responses are important in joint disorders and an alteration in ERalpha and ERbeta expression would have an impact on how estrogen affects the immune response in the TMJ.
###end p 12
###begin p 13
###xml 216 218 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 465 467 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 468 470 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 266 269 <span type="species:ncbi:10116">rat</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 378 384 <span type="species:ncbi:9557">baboon</span>
In particular, ERalpha was found in the articular cartilage and subchondral bone of TMJ which implies that estrogen directly acted on the cells in the TMJ tissue to alter the gene expression and cellular physiology [19]. In contrast to the ERalpha expression in the rat, ERalpha nuclear staining was not detected in the bone, cartilaginous or connective tissues of the human or baboon TMJ, but it was present in the immune cells such as macrophage and lymphocytes [20,21].
###end p 13
###begin p 14
###xml 90 92 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 93 95 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 163 165 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 166 168 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 353 355 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 492 494 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 495 497 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
In addition ER knockout studies have shown a major role for ERalpha in immune modulation [22,23]. Because ERalpha is present in the immune cells in the human TMJ [20,21], a likely target of 17 beta-estradiol in the human TMJ is ERalpha-positive immune cells. Furthermore ER-alpha gene polymorphisms is associated with a predisposition to TMJ disorders [24]. Such data from both animal and clinical studies support a significant role of ERalpha in the increased incidence of TMJ inflammation [24,25].
###end p 14
###begin p 15
###xml 99 101 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 561 563 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 13 16 <span type="species:ncbi:10116">rat</span>
In an intact rat 17 beta-estradiol and progesterone concentrations change during the estrus cycle [26]. Multiple fluctuating hormones could complicate our understanding of how 17 beta-estradiol modulates estrogen receptor expression. Hormone administration in overiectomized animals allows us to study the effect of 17 beta-estradiol, avoiding fluctuating levels. Thus, our study was focused on the effect of a single, physiological concentration of 17 beta-estradiol. This concentration of 17 beta-estradiol was equal to that observed during the estrus cycle [26].
###end p 15
###begin p 16
###xml 154 156 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 356 359 <span type="species:ncbi:10116">rat</span>
The level of receptor will determine the cellular sensitivity to 17 beta-estradiol, because this hormone acts primarily through the estrogen receptor(s) [27]. This paper particularly focuses on ERalpha expression in response to17beta-estradiol and inflammation. The aim of the present study is to first quantify the tissue content of ERalpha in the female rat TMJ, and second, to determine whether changes in the ERalpha expression in the TMJ result from alterations in inflammation or the concentration of 17beta-estradiol.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Animals and tissue preparation
###end title 18
###begin p 19
###xml 962 964 956 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 134 138 <span type="species:ncbi:10116">rats</span>
###xml 221 225 <span type="species:ncbi:10116">rats</span>
###xml 324 328 <span type="species:ncbi:10116">rats</span>
###xml 425 429 <span type="species:ncbi:10116">rats</span>
###xml 814 817 <span type="species:ncbi:31658">CFA</span>
The Baylor College of Dentistry Institutional Animal Care and Use Committee approved the experimental protocol. Female Sprague Dawley rats (~230 gm) were ovariectomized by Harlan Industries, Houston TX. Upon arrival, the rats were housed individually and kept on a 14:10 h light/dark cycle with lights on at 0600 h. All the rats were anesthetized with ketamine (45 mg/kg) and rompun (4.8 mg/kg). Using sterile technique, the rats were implanted with primed, 14-day Alzet mini-osmotic pumps dispensing vehicle, polyethylene glycol (no estrogen replacement control group) or 750 ng/day of 17beta-estradiol benzoate. These animals were then subdivided further; one group received bilateral injections of 0.9% saline (30 mul) and the other group received an injection of 30 mug (30 mul) of complete Freund's adjuvant (CFA) within the superior joint space of the TMJ just above the disc. The animals were removed from their cages and sacrificed with an overdose of CO2 after 48 h. The animals were decapitated; blood collected and the heads were placed in plastic bags and submerged in ice water. For western analysis, the TMJ anterior, disc, retrodiscal and synovium were dissected from one side by performing a superficial, horizontal skin incision parallel and just inferior to the zygomatic arch. The masseter and temporalis muscles were cut away from the arch and the ramus of the mandible so that the arch could be removed with ronjeurs. The neck of the condyle was grasped with hemostats and the condylar neck fractured to allow removal of any remaining musculature and access to the anterior, disc, retrodiscal and synovial tissues. Dissected TMJ tissue was excised from the posterior neck of the condyle, and all anterior tissue, articular disc, retrodiscal tissue and synovium were removed, placed in liquid nitrogen and stored at -80degreesC. For histological analysis, a 0.5 cm cube of TMJ tissue centered on the condyle was removed, en bloc, from the other side and placed in 4% paraformaldehyde at 4degreesC overnight. The tissue was then decalcified in 10% EDTA for 2 weeks, embedded in paraffin wax and 8 mum sections were cut and mounted on Superfrost glass slides (Fisher Scientific, Pittsburgh, PA) for immunohistochemical or hematoxylin and eosin staining.
###end p 19
###begin title 20
Quantitation of hormone levels
###end title 20
###begin p 21
17 beta-estradiol was quantitated in the blood plasma by first, vigorously mixing 0.5 ml of plasma with 5 ml of ether. Second, the solution was frozen in an ethanol, dry ice bath and the ether phase decanted. The ether phase contains the lipid soluble hormones. The ether was evaporated and the remaining residue suspended in RIA buffer supplied by the manufacturer. The concentration of 17 beta-estradiol was quantitated following the manufactures directions (ICN Biomedicals, Costa Mesa, CA).
###end p 21
###begin title 22
Western blot analysis
###end title 22
###begin p 23
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
###xml 897 901 <span type="species:ncbi:9925">goat</span>
###xml 907 912 <span type="species:ncbi:10090">mouse</span>
###xml 946 957 <span type="species:ncbi:3704">horseradish</span>
###xml 1358 1362 <span type="species:ncbi:9925">goat</span>
###xml 1368 1374 <span type="species:ncbi:9986">rabbit</span>
The previously isolated, frozen TMJ anterior, disc, retrodiscal and synovial tissues were homogenized in ice-cold protein-extraction buffer (75 mM potassium acetate pH 7.4, 300 mM NaCl, 10 mM EDTA, .25% Triton X-100, protease inhibitors), centrifuged at 7500 g for 15 min at 4degreesC, and the resulting supernatant was collected and stored at -20degreesC. Each sample was tested for protein content by standard BCA assay (Thermo Fisher Scientific, Rockford, IL); 10 mug of total protein was loaded onto a SDS PAGE, separated by electrophoresis, transferred to a membrane, and the membrane was blocked with 1.5% v/v BSA in TBS-T (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20) for 2 h at room temperature. After blocking, the ERalpha mouse monoclonal antibody (Thermo Fisher Scientific) was added at a dilution of 1:1000 overnight at 4degreesC. The membrane was then incubated for 2 h with a goat anti-mouse secondary antibody conjugated to horseradish peroxidase. The products were detected by means of an enhanced chemiluminescence light detection kit (Bio-Rad, Hercules, CA). After detection of the ERalpha band the blot was stripped according to the manufactures directions with Erase-It (Thermo Fischer Scientific, Rockford, IL) and re-probed with a beta-actin antibody (Cell Signaling, Boston, MA) at a dilution of 1:000 followed by addition of a goat anti-rabbit secondary, detection and development of the film. The BioMax films (Kodak, Rochester, New York) were developed, digitally scanned, and the integrated optical density of the resulting bands was collected and analyzed using Scion Image (Scion Corporation, Frederick, MD).
###end p 23
###begin title 24
Immunocytochemistry
###end title 24
###begin p 25
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 309 307 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1103 1106 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th </sup>
###xml 1179 1181 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 351 355 <span type="species:ncbi:9925">goat</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 513 517 <span type="species:ncbi:9925">goat</span>
###xml 695 699 <span type="species:ncbi:9925">goat</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 771 777 <span type="species:ncbi:9986">rabbit</span>
###xml 783 787 <span type="species:ncbi:9925">goat</span>
The paraffin wax was removed from the tissue sections, and then the sections were processed for staining with hematoxylin and eosin or for immunohistochemistry. Light microscope images were captured by Zeiss Axioplan. Immunohistochemistry was completed by first quenching endogenous peroxidase with 0.3% H2O2 in PBS for 30 min, blocking in 10% normal goat serum and PBS for 1 h and then incubating the slide with two primary antibodies; mouse anti-ERalpha antibody diluted to 1:250 (Thermo Fisher Scientific) and goat polyclonal CD14 (Santa Cruz Biotechnology) diluted to 1:100 overnight at 4degreesC. The sections were subsequently treated with two fluorescent conjugated secondary antibodies (goat anti-mouse Alexa 488 (Invitrogen, Carlsbad, CA) at 1:2000 dilution and rabbit anti-goat Alexa 633 in PBS at 1:500 (Molecular Probes) for an hour at room temperature. The sections were rinsed and then cover-slipped with fluoromount-G medium (Southern Biotech, Birmingham, AL) containing DAPI counterstain. The total (DAPI positive) and ERalpha positive cells (Alexa 488 positive) were counted on every 10th section to obtain a representative sample through the entire TMJ region [28] using a Nikon epifluorescent microscope. The images were also analyzed with a Leica TCS-SP2 confocal microscope and arranged with Adobe Photoshop.
###end p 25
###begin title 26
Data and statistical analysis
###end title 26
###begin p 27
The data were analyzed using two-way ANOVA using the factors of hormone and inflammation. Data that showed a significant group effect were further analyzed using a Bonferroni post-hoc test. P-values of < 0.05 were considered to be statistically significant. The results were expressed as the mean and standard error of the mean (SEM).
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 169 170 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 363 365 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 7 10 <span type="species:ncbi:10116">rat</span>
###xml 239 243 <span type="species:ncbi:10116">rats</span>
###xml 333 337 <span type="species:ncbi:10116">rats</span>
In the rat, Alzet pumps released 750 ng/day of 17 beta-estradiol benzoate. This amount produced a plasma 17 beta-estradiol concentration of approximately 20 pg/ml (Fig. 1), a concentration that was significantly higher than ovariectomized rats receiving vehicle and was similar to the amount of plasma 17 beta-estradiol reported for rats during the estrus cycle [26].
###end p 29
###begin p 30
###xml 0 78 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Concentration of 17 &#946;-estradiol in the plasma of ovariectomized female rats</bold>
###xml 164 166 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 225 226 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 257 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 261 263 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 510 511 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 549 551 544 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 593 594 588 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 636 637 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 675 677 670 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 714 715 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 805 807 800 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1007 1009 997 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 74 78 <span type="species:ncbi:10116">rats</span>
###xml 101 105 <span type="species:ncbi:10116">rats</span>
###xml 233 237 <span type="species:ncbi:10116">rats</span>
###xml 387 390 <span type="species:ncbi:31658">CFA</span>
###xml 462 466 <span type="species:ncbi:10116">rats</span>
###xml 525 529 <span type="species:ncbi:10116">rats</span>
###xml 608 612 <span type="species:ncbi:10116">rats</span>
###xml 627 630 <span type="species:ncbi:31658">CFA</span>
###xml 638 641 <span type="species:ncbi:31658">CFA</span>
###xml 651 655 <span type="species:ncbi:10116">rats</span>
###xml 686 689 <span type="species:ncbi:31658">CFA</span>
###xml 716 719 <span type="species:ncbi:31658">CFA</span>
Concentration of 17 beta-estradiol in the plasma of ovariectomized female rats. Ovariectomized (OVX) rats were implanted with Alzet pumps dispensing 750 ng/day of E2 or the same volume of the vehicle polyethylene glycol (no E2). OVX rats infused with no E2 or E2 were given a 30 mul intra-articular temporomandibular joint (TMJ) injection of saline or 30 mug complete Freund's adjuvant (CFA) seven days after pump implantation. Treatment groups consisted of OVX rats having their TMJ injected with saline (No E2/saline); OVX rats supplemented with E2 that had saline injected into their TMJ (E2/saline); OVX rats injected with CFA (No E2/CFA) and OVX rats supplemented with E2 that had CFA injected into the TMJ (E2/CFA). 48 h following TMJ injection the animals were sacrificed and the concentration of E2 was measured in the plasma by radio-immunoassay. The histogram shows the mean +/- SEM concentration of 17 beta-estradiol per ml of plasma from the pooled values of four animals per treatment group, * p < 0.05.
###end p 30
###begin p 31
###xml 183 185 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 190 192 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 207 209 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 214 216 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 369 371 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 197 200 <span type="species:ncbi:31658">CFA</span>
###xml 307 310 <span type="species:ncbi:31658">CFA</span>
###xml 358 362 <span type="species:ncbi:10116">rats</span>
After performing a western blot on the samples from the TMJ no significant change in ERalpha expression was found due to administration of 17 beta-estradiol in either the saline (Fig 2A and 2B) or CFA (Fig. 2A and 2C) injected group. The amount of ERalpha protein significantly decreased after injection of CFA into both vehicle or 17 beta-estradiol treated rats (Fig. 2A).
###end p 31
###begin p 32
###xml 0 132 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Western blot of protein isolated from the temporomandibular joint (TMJ) of ovariectomized female rats treated with 17 &#946;-estradiol</bold>
###xml 197 198 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 216 217 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 97 101 <span type="species:ncbi:10116">rats</span>
###xml 155 159 <span type="species:ncbi:10116">rats</span>
###xml 331 334 <span type="species:ncbi:31658">CFA</span>
Western blot of protein isolated from the temporomandibular joint (TMJ) of ovariectomized female rats treated with 17 beta-estradiol. Ovariectomized (OVX) rats were given a physiological dose of (E2) or vehicle (No E2) using osmotic pumps and after 7 days of estrogen treatment the TMJ was injected with 30 mul of saline or 30 mug CFA. Protein from the TMJ anterior, disc, retrodiscal and synovial tissues was isolated, 10 mug of protein was loaded in each lane of the gel and the western blot was probed with anti-ERalpha and then anti-beta-actin. (A) Optical densities of the ERalpha specific band (65 kDa) were determined from the western blot and the optical density of the ERalpha specific band was normalized to the beta-actin band. The normalized mean +/- SEM optical density values are shown in the histogram. Each lane in panels B and C is a representative sample from one animal in each treatment group. ** = p < 0.01.
###end p 32
###begin p 33
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 473 474 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 598 599 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 66 70 <span type="species:ncbi:10116">rats</span>
###xml 85 88 <span type="species:ncbi:31658">CFA</span>
###xml 166 170 <span type="species:ncbi:10116">rats</span>
###xml 262 266 <span type="species:ncbi:10116">rats</span>
###xml 339 342 <span type="species:ncbi:31658">CFA</span>
###xml 684 687 <span type="species:ncbi:31658">CFA</span>
Swelling was observed in the retrodiscal tissue of ovariectomized rats injected with CFA (Fig. 3B). This was in contrast to the retrodiscal tissue of saline injected rats that had no swelling (Fig. 3A). Similar levels of swelling were observed in ovariectomized rats injected with vehicle or 17 beta-estradiol that were then injected with CFA (data not shown). Nuclear and cytoplasmic ERalpha immunostaining was observed in the highly vascularized retrodiscal tissue (Fig. 4) and in the synovial lining cells. Double stained ERalpha and CD14 positive cells were found in the retrodiscal area (Fig. 4) and synovium of all four groups. These double labelled cells were observed more in CFA injected group as compared to saline group. When the primary antibody was not added (negative control), no signal was observed (data not shown).
###end p 33
###begin p 34
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Histology of sagittal section of a female rat temporomandibular joint</bold>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 231 234 <span type="species:ncbi:10116">rat</span>
Histology of sagittal section of a female rat temporomandibular joint. (A) Representative image of a vehicle treated OVX rat 48 h after injecting 30 mul of saline. (B) Representative image of a vehicle-treated ovariectomized (OVX) rat 48 h after injecting 30 mul of complete Freund's adjuvant in the upper joint space of the temporomandibular (TMJ). The TMJ was removed en bloc 48 h after injection, paraffin-embedded, sectioned at 8 mum and stained with hematoxylin and eosin. Sight of inflamed tissue is indicated by black arrowheads. Size bar = 500 mum
###end p 34
###begin p 35
###xml 0 121 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Immunofluorescent staining of ER&#945; and CD14 observed in the retrodiscal tissue of the TMJ in all four treatment groups</bold>
###xml 130 131 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 148 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 158 159 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 173 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 152 <span type="species:ncbi:31658">CFA</span>
###xml 174 177 <span type="species:ncbi:31658">CFA</span>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
###xml 255 259 <span type="species:ncbi:9925">goat</span>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 362 366 <span type="species:ncbi:9925">goat</span>
Immunofluorescent staining of ERalpha and CD14 observed in the retrodiscal tissue of the TMJ in all four treatment groups. A) No E2/saline, B) No E2/CFA, C) E2/saline, D) E2/CFA. The sections were immunohistochemically stained with mouse anti-ERalpha and goat polyclonal anti- CD14 primary antibodies followed by anti-mouse Alexa 488 conjugated (green) and anti-goat Alexa 633 conjugated (red) secondary respectively. ERalpha nuclear with CD14 cytoplasmic staining (arrows), ERalpha cytoplasmic staining (arrowhead), ERalpha nuclear staining (open arrowhead) and CD14 staining (open arrow) were observed. Size bar for A, B, D = 47.5 mum.; C = 50 mum.
###end p 35
###begin p 36
###xml 155 157 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 375 376 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 514 515 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 528 529 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 545 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 692 693 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 703 704 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 847 848 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 861 862 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 903 904 870 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 920 921 887 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 932 934 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 1007 1009 974 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1189 1191 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 1309 1311 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 480 484 <span type="species:ncbi:10116">rats</span>
###xml 664 668 <span type="species:ncbi:10116">rats</span>
###xml 694 697 <span type="species:ncbi:31658">CFA</span>
###xml 705 708 <span type="species:ncbi:31658">CFA</span>
###xml 738 741 <span type="species:ncbi:31658">CFA</span>
###xml 812 816 <span type="species:ncbi:10116">rats</span>
###xml 863 866 <span type="species:ncbi:31658">CFA</span>
###xml 879 883 <span type="species:ncbi:10116">rats</span>
###xml 922 925 <span type="species:ncbi:31658">CFA</span>
###xml 1179 1182 <span type="species:ncbi:31658">CFA</span>
###xml 1289 1292 <span type="species:ncbi:31658">CFA</span>
ERalpha-positive cells were counted in the anterior, disc, retrodiscal and synovial tissue, but few ERalpha-positive cells were observed in the disc (Fig. 5A). Of the total cells observed, the counts showed that 84% of the ERalpha-positive stained cells were in the retrodiscal tissue, 13% of the cells were in the anterior tissue and 3% in the synovium. 17 beta-estradiol (E2) treatment significantly decreased the number of cells expressing ERalpha in the retrodiscal tissue of rats with a non-inflamed TMJ (No E2/saline vs. E2/saline; Fig. 5A). The number of cells expressing ERalpha in the inflamed retrodiscal tissue of the TMJ was unchanged after giving the rats 17 beta-estradiol (No E2/CFA vs. E2/CFA). In the retrodiscal tissue, CFA significantly increased the number of ERalpha positive cells in those rats receiving 17 beta-estradiol (E2/saline vs. E2/CFA) but not in rats given vehicle (No E2/saline vs. no E2/CFA; Fig. 5A). (Though there was a trend showing a higher number of cells in the No E2 saline group, the number of cells expressing ERalpha did not significantly change in the anterior, disc or synovium of the TMJ as a result of giving 17 beta-estradiol or CFA (Fig. 5A). Also, the total number of cells in these tissues did not change following 17 beta-estradiol or CFA treatment (Fig. 5B).
###end p 36
###begin p 37
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cell counts within the TMJ</bold>
###xml 201 202 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 227 228 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 361 362 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 375 376 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 383 384 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 394 395 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 153 <span type="species:ncbi:10116">Rats</span>
###xml 319 322 <span type="species:ncbi:31658">CFA</span>
###xml 377 380 <span type="species:ncbi:31658">CFA</span>
###xml 396 399 <span type="species:ncbi:31658">CFA</span>
Cell counts within the TMJ. Quantitation of (A) ERalpha-containing cells and (B) the total number of cells within the temporomandibular joint (TMJ). Rats were given a constant infusion of vehicle (No E2) or 17 beta-estradiol (E2) using osmotic pumps for one week, and then the TMJ was injected with saline or 30 mug of CFA to produce four treatment groups: No E2/saline, No E2/CFA, E2/saline, E2/CFA. The TMJ was removed en bloc 48 h after TMJ injection, paraffin-embedded, sectioned at 8 mum and immunostained for ERalpha (Alexa 488 positive) and counterstained with DAPI. The histogram shows the number of ERalpha-positive stained cells in each of the four tissues (i.e., anterior, disc, retrodiscal and synovial) for each treatment group. Counts included cells with cytoplasmic and nuclear ERalpha staining. Following staining, the number of DAPI-positive cells in each tissue region was counted for each treatment group. Bars on the histogram were generated from the cell counts of four different animals per treatment group whose values were pooled to give a mean +/- SEM. * = p < 0.05.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 210 212 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 69 73 <span type="species:ncbi:10116">rats</span>
###xml 191 195 <span type="species:ncbi:10116">rats</span>
###xml 233 237 <span type="species:ncbi:10116">rats</span>
###xml 295 298 <span type="species:ncbi:31658">CFA</span>
###xml 432 436 <span type="species:ncbi:10116">rats</span>
In these studies we administered 17 beta-estradiol to ovariectomized rats such that the plasma concentration of hormone was physiological and similar to the concentration observed during the rats estrus cycle [26]. In ovariectomized rats, treated with and without 17beta-estradiol, injection of CFA into the TMJ induced swelling of the retrodiscal tissue. Induction of inflammation decreased the expression of ERalpha in the TMJ of rats injected with and without 17beta-estradiol. 17 beta-estradiol reduced the number of ERalpha positive cells in the retrodiscal tissue but only in animals that did not have an inflammation, suggesting first that 17 beta-estradiol acts in a tissue specific manner in the TMJ region and second that the inflammation can alter the effect of estradiol.
###end p 39
###begin p 40
###xml 429 430 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 498 499 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1156 1158 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1256 1258 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1345 1347 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1348 1350 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1984 1986 1915 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 2204 2206 2135 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 2309 2311 2237 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 102 105 <span type="species:ncbi:31658">CFA</span>
###xml 500 503 <span type="species:ncbi:31658">CFA</span>
###xml 526 529 <span type="species:ncbi:31658">CFA</span>
###xml 699 702 <span type="species:ncbi:31658">CFA</span>
###xml 901 904 <span type="species:ncbi:31658">CFA</span>
###xml 1148 1154 <span type="species:ncbi:9606">humans</span>
###xml 1636 1639 <span type="species:ncbi:31658">CFA</span>
###xml 1818 1821 <span type="species:ncbi:10116">rat</span>
Knowing that on western blots estrogen receptor levels decreased in the TMJ region after injection of CFA, the question arose as to whether this decrease was due to a reduction in the number of cells expressing the receptor or to a decrease in the number of receptors per cell. For this reason we counted the number of cells expressing ERalpha. In the anterior and synovial tissue the number of ERalpha positive cells in the No E2/saline group trended (showed a trend to be) higher than in the No E2/CFA group, suggesting the CFA induced a decrease in ERalpha levels, consistent with the western results. Animals receiving 17 beta-estradiol had a decreased amount of ERalpha on a western blot after CFA injection, but the number of ERalpha positive cells increased in the anterior and retrodiscal tissue. Whereas in the synovium the number of ERalpha positive cells did display a downward trend after CFA injection. Double stained ERalpha and CD14 positive immune cells observed in the retrodiscal area and synovium of all four groups suggest the presence of ERalpha positive immune cells consistent with the ERalpha-positive immune cells found in humans [20]. Another study also shows that the synovium is highly populated with monocytes and macrophages [29]. Macrophage-like and fibroblast-like synoviocytes stain for both ERalpha and ERbeta [30-32]. Although few in number, the ERalpha positive cells in the synovium might have much higher amounts of ERalpha per cell than the retrodiscal tissue. In the event that a majority of the ERalpha protein from the TMJ was derived from the synovium we would see a decrease in ERalpha after CFA injection, consistent with our western blot results. Our results showing that different tissues had a different response to 17 beta-estradiol was consistent with studies done on rat uterus, demonstrating the upregulation of ERalpha in the stromal cells and its concurrent downregulation in the epithelia of the uterus in response to estradiol [33]. Expression of the immune complex protein C3 was shown to be upregulated in the uterine epithelial cells in response to estradiol whereas expression in the liver was unaffected by the same concentration of estrogen [34]. In joint tissue 17 beta-estradiol alters proteoglycan metabolism differently depending on location [35].
###end p 40
###begin p 41
###xml 101 104 <span type="species:ncbi:31658">CFA</span>
In the retrodiscal tissue the number of ERalpha positive cells increased or remained unchanged after CFA injection but the amount of ERalpha in each cell may have decreased leading to a reduction in the ERalpha observed on the western blot. To determine whether an increase in the expression per cell results in a higher expression of estrogen receptor, we needed to quantitate the fluorescent signal in each cell. Unfortunately, the florescent signal faded rapidly and we could not determine the intensity of staining per cell (i.e. ERalpha expression per cell) and thus, we could not determine what led to the decrease in estrogen receptor signal on the western blot.
###end p 41
###begin p 42
###xml 235 237 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 331 333 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 334 336 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 463 465 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 466 468 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 866 868 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 975 977 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1163 1165 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
###xml 130 136 <span type="species:ncbi:9606">humans</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
The number of cells expressing ERalpha in the retrodiscal tissue was significantly lower in the 17 beta-estradiol-treated rat. In humans, the estrogen receptors are present on peri-vascular immune cells (e.g., macrophages) in the TMJ [20]. 17 beta-estradiol treatment has been shown to modulate gene expression in the macrophages [36-38]. In vivo studies have shown that macrophage proliferation increases with an increased estrogen concentration in female mice [39,40], implying that estrogen can increase ERalpha levels though stimulation of macrophage proliferation. Since we did not see an increase in ERalpha positive cell numbers, macrophage proliferation was not a likely cause for the increased ERalpha expression. Another possible explanation for the reduction in ERalpha expression may be that 17beta-estradiol caused a down-regulation of gene expression [41] similar to previous studies that indicated 17beta-estradiol inhibits ERalpha expression in joint tissue [42]. Interestingly, this previous study also showed that inflammation effectively blocked the inhibitory effect of 17beta-estradiol, consistent with our results in the retrodiscal tissue [42].
###end p 42
###begin p 43
###xml 156 158 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 159 161 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 319 321 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 322 324 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
Studies have also demonstrated decreased specific binding of radiolabeled 17beta-estradiol with E2 treatment which resulted in a depletion of cytosolic ER [43,44]. Down-regulation of estrogen receptor was suggested to involve some transcriptional activation mechanisms such as proteasome-mediated proteolysis activity [45,46].
###end p 43
###begin title 44
Conclusions
###end title 44
###begin p 45
A constant physiological concentration of 17 beta-estradiol effects ERalpha expression in a non-inflamed and inflamed TMJ. But several questions remain such as what are the effects of 17 beta-estradiol on ERbeta in the TMJ tissues and what are the effects of progesterone or pregnancy levels of 17 beta-estradiol. Future studies would need to focus on the amount of receptor per cell in different tissues as well as determine the effect of higher concentrations of 17 beta-estradiol such as that occuring during pregnancy (120 pg/ml). These studies might help develop estrogenic medications for TMJ pain. Moreover, progesterone could impact estrogen receptor expression and interact with 17 beta-estradiol to alter its effects.
###end p 45
###begin title 46
Competing interests
###end title 46
###begin p 47
The authors declare that they have no competing interests.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
JP, BH and PRK participated in the design of the study, data collection, statistical analysis, and manuscript drafting. All authors read and approved the final manuscript.
###end p 49
###begin title 50
Acknowledgements
###end title 50
###begin p 51
We thank Connie Tillberg and Vanessa Winger for their technical expertise. We gratefully acknowledge research support from NIDCR grant DE016059-01 to LLB and DE15372 to PRK.
###end p 51
###begin article-title 52
Gonadal steroids and immunity
###end article-title 52
###begin article-title 53
###xml 69 73 <span type="species:ncbi:10116">rats</span>
The effect of ovariectomy on the temporomandibular joints of growing rats
###end article-title 53
###begin article-title 54
###xml 87 91 <span type="species:ncbi:10116">rats</span>
Effect of estrogen replacement on temporomandibular joint remodeling in ovariectomized rats
###end article-title 54
###begin article-title 55
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Effects of sex hormones on protein and collagen content of the temporomandibular joint disc of the rat
###end article-title 55
###begin article-title 56
Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthodial joint fibrocartilaginous cells but not in synoviocytes
###end article-title 56
###begin article-title 57
Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss
###end article-title 57
###begin article-title 58
The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthitis
###end article-title 58
###begin article-title 59
Matrix metalloproteinases: role in arthitis
###end article-title 59
###begin article-title 60
###xml 40 45 <span type="species:ncbi:9606">human</span>
Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthitis
###end article-title 60
###begin article-title 61
Estrogenic effect on swelling and monocytic receptor expression in an arthitic temporomandibular joint model
###end article-title 61
###begin article-title 62
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Testosterone and estrogen have opposing actions on inflammation-induced plasma extravasation in the rat temporomandibular joint
###end article-title 62
###begin article-title 63
Mechanisms of estrogen action
###end article-title 63
###begin article-title 64
Estrogen signaling multiple pathways to impact gene transcription
###end article-title 64
###begin article-title 65
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus
###end article-title 65
###begin article-title 66
Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells
###end article-title 66
###begin article-title 67
The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis
###end article-title 67
###begin article-title 68
Mechanism for normal splenic T lymphocyte functions in proestrous females after trauma: enhanced local synthesis of 17 beta-estradiol
###end article-title 68
###begin article-title 69
Estrogen, prolactin, and autoimmunity: actions and interactions
###end article-title 69
###begin article-title 70
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Expression of estrogen receptor alpha [ER alpha] in the rat temporomandibular joint
###end article-title 70
###begin article-title 71
###xml 68 73 <span type="species:ncbi:9606">human</span>
Analysis of estrogen binding sites of the posterior ligament of the human TMJ
###end article-title 71
###begin article-title 72
###xml 106 112 <span type="species:ncbi:9557">baboon</span>
Sexual dimorphism in the distribution of estrogen receptors in the temporomandibular joint complex of the baboon
###end article-title 72
###begin article-title 73
Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations
###end article-title 73
###begin article-title 74
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Influence of oestrogen receptor alpha and beta on the immune system in aged female mice
###end article-title 74
###begin article-title 75
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients
###end article-title 75
###begin article-title 76
Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder
###end article-title 76
###begin article-title 77
###xml 120 123 <span type="species:ncbi:10116">rat</span>
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17 beta thoughout the 4-day estrous cycle of the rat
###end article-title 77
###begin article-title 78
Molecular mechanisms of action of steroid/thyroid receptor superfamily members
###end article-title 78
###begin article-title 79
2-D versus 3-D cell counting--a debate. What is an optical disector?
###end article-title 79
###begin article-title 80
The synovial lining cell: biology and pathobiology
###end article-title 80
###begin article-title 81
Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium
###end article-title 81
###begin article-title 82
###xml 79 84 <span type="species:ncbi:9606">human</span>
Expression of estrogen receptor related protein [p29] and estradiol binding in human arthitic synovium
###end article-title 82
###begin article-title 83
Sex steroid receptors in rheumatoid arthitis
###end article-title 83
###begin article-title 84
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Effect of estradiol on estrogen receptor expression in rat uterine cell types
###end article-title 84
###begin article-title 85
Estrogen regulation of tissue-specific expression of complement C3
###end article-title 85
###begin article-title 86
Effects of estrogen on cartilage and experimentally induced osteoarthitis
###end article-title 86
###begin article-title 87
17 beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes
###end article-title 87
###begin article-title 88
17 beta-estradiol regulates cytokine release though modulation of CD16 expression in monocytes and monocyte-derived macrophages
###end article-title 88
###begin article-title 89
17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis
###end article-title 89
###begin article-title 90
Apparent role of the macrophage growth factor, CSF-1, in placental development
###end article-title 90
###begin article-title 91
Macrophages, synovial tissue and rheumatoid arthitis
###end article-title 91
###begin article-title 92
Estrogen receptor down-regulation is regulated noncooperatively by estrogen at the transcription level
###end article-title 92
###begin article-title 93
Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway
###end article-title 93
###begin article-title 94
Estrogen-binding substances of target tissues
###end article-title 94
###begin article-title 95
Control of estrogen binding protein concentration under basal conditons and after estrogen administration
###end article-title 95
###begin article-title 96
Implication of proteasome in estrogen receptor degradation
###end article-title 96
###begin article-title 97
###xml 40 45 <span type="species:ncbi:9606">human</span>
Proteasome dependent degradation of the human estrogen receptor
###end article-title 97

